HomeNBTX • NASDAQ
add
Nanobiotix SA - ADR
Previous close
$6.32
Day range
$6.41 - $6.67
Year range
$4.55 - $11.00
Market cap
310.37M USD
Avg Volume
68.74K
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 16.46M | 854.89% |
Operating expense | 15.89M | 31.06% |
Net income | -5.80M | 62.19% |
Net profit margin | -35.25 | 96.04% |
Earnings per share | — | — |
EBITDA | 706.50K | 106.89% |
Effective tax rate | -1.02% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 75.28M | 81.90% |
Total assets | 93.90M | 57.10% |
Total liabilities | 95.74M | 10.28% |
Total equity | -1.84M | — |
Shares outstanding | 47.11M | — |
Price to book | -158.00 | — |
Return on assets | 1.52% | — |
Return on capital | 2.92% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.80M | 62.19% |
Cash from operations | 2.40M | 124.50% |
Cash from investing | -11.00K | -125.88% |
Cash from financing | 24.45M | 2,380.14% |
Net change in cash | 26.83M | 348.02% |
Free cash flow | 409.38K | 106.66% |
About
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
CEO
Founded
2003
Website
Employees
102